Table 2.
Association between clinical/demographic variables and mortality in alp patients
| Variable | Total Cases (n) | Survivors (n = 29) | Mortality (n = 12) | Mortality Rate (%) | P-value |
|---|---|---|---|---|---|
| Ingestion Method | 0.006* | ||||
| Not Dissolved (Direct) | 20 | 10 | 10 | 50.0% | |
| Dissolved in Water | 15 | 14 | 1 | 6.7% | |
| Unknown | 6 | 5 | 1 | 16.7% | |
| Clinical Course (within 48 h)† | < 0.001* | ||||
| Hypotension | |||||
| Present | 18 | 6 | 12 | 66.7% | |
| Absent | 17 | 17 | 0 | 0.0% | |
| Metabolic Acidosis | 0.003* | ||||
| Present | 19 | 10 | 9 | 47.4% | |
| Absent | 16 | 16 | 0 | 0.0% | |
| ICU Admission | < 0.05* | ||||
| Required | 20 | 13 | 7 | 35.0% | |
| General Ward | 21 | 16 | 5 | 23.8% | |
| Demographics | |||||
| Gender | 0.65 (NS) | ||||
| Male | 22 | 15 | 7 | 31.8% | |
| Female | 19 | 14 | 5 | 26.3% | |